Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.98Price to Book
VS
Market
Sector
Industry
History
$ 4.11Close
$ 1.25 - $ 4.32 52-Week Range
Ticker Information
Ticker
BDTXCompany Name
BLACK DIAMOND THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBLACK DIAMOND THERAPEUTICS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BDTX - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 132.61M | $ 129.81M | 0.98 |
| 3/31/2025 | $ 141.52M | $ 99.51M | 0.7 |
| 12/31/2024 | $ 83.28M | $ 107.66M | 1.29 |
| 9/30/2024 | $ 97.43M | $ 183.9M | 1.89 |
| 6/30/2024 | $ 111.02M | $ 282.81M | 2.55 |
| 3/31/2024 | $ 104.31M | $ 379.71M | 3.64 |
| 12/31/2023 | $ 116.74M | $ 195.49M | 1.67 |
| 9/30/2023 | $ 134.32M | $ 98.62M | 0.73 |
| 6/30/2023 | $ 82.2M | $ 171.75M | 2.09 |
| 3/31/2023 | $ 98.19M | $ 66.45M | 0.68 |
Key Performance Insights, Last 5 Years
- BLACK DIAMOND THERAPEUTICS INC's latest trailing twelve months (TTM) P/B stands at 3.74.
- Over the past 5 years, BLACK DIAMOND THERAPEUTICS INC's average P/B has been 1.58.
- The median P/B for BLACK DIAMOND THERAPEUTICS INC during this period was 1.33
- BLACK DIAMOND THERAPEUTICS INC reached its highest P/B over the past 5 years at 3.74.
- The lowest P/B recorded by BLACK DIAMOND THERAPEUTICS INC in the same timeframe 0.39
BLACK DIAMOND THERAPEUTICS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for BLACK DIAMOND THERAPEUTICS INC is calculated as follows: Market Cap [ $ 1.22B ] / Equity [ $ 327.35M ]
(=) P/B [ 3.74 ] BDTX - Price to Book, Last 5 years
0.39
Minimum
Mar 31, 2022
3.74
Maximum
Sep 30, 2020
1.58
Average
1.33
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |